Please login to the form below

Not currently logged in
Email:
Password:

GK Strategy

This page shows the latest GK Strategy news and features for those working in and with pharma, biotech and healthcare.

Avenir acquires Cherry, EY wins new account and GK unites businesses

Avenir acquires Cherry, EY wins new account and GK unites businesses

GK merge businesses. Strategic communications and public affairs consultancy GK Strategy, has merged with its sister political due diligence adviser GK intelligence. ... As one team, GK Strategy’s offer is clearer to clients and will enable us to be an

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • GK Strategy appoints head of health and social care GK Strategy appoints head of health and social care

    Andrew Nye joins the public affairs consultancy. Public affairs consultancy GK Strategy has appointed Andrew Nye to the newly-created position of head of health and social care. ... Emily Wallace, chief executive of GK Strategy, said: “Andrew joins GK

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics